Commonwealth Retirement Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,579
Closed -$189K 338
2025
Q4
$189K Sell
7,579
-19,707
-72% -$497K 0.06% 126
2025
Q3
$695K Sell
27,286
-9,195
-25% -$227K 0.24% 82
2025
Q2
$884K Sell
36,481
-3,550
-9% -$82.8K 0.34% 76
2025
Q1
$1.01M Buy
40,031
+14,775
+59% +$387K 0.41% 61
2024
Q4
$670K Sell
25,256
-16,701
-40% -$453K 0.28% 73
2024
Q3
$1.21M Sell
41,957
-6,417
-13% -$187K 0.51% 54
2024
Q2
$1.35M Sell
48,374
-138,694
-74% -$3.82M 0.62% 50
2024
Q1
$5.19M Buy
187,068
+89,065
+91% +$2.47M 2.48% 13
2023
Q4
$2.82M Sell
98,003
-50,478
-34% -$1.53M 1.49% 20
2023
Q3
$4.93M Buy
148,481
+8,067
+6% +$285K 2.84% 15
2023
Q2
$5.15M Buy
140,414
+11,539
+9% +$449K 2.87% 13
2023
Q1
$5.26M Buy
128,875
+3,413
+3% +$147K 3.12% 12
2022
Q4
$6.43M Buy
+125,462
New +$6.02M 3.9% 6

Other funds holding PFE

Commonwealth Retirement Investments's PFE Position: Q1 2026 in Review

Commonwealth Retirement Investments sold out of Pfizer (PFE) in Q1 2026, closing a stake of 7,579 shares — an estimated $189K sold.

Commonwealth Retirement Investments first reported a position in PFE in Q4 2022 and held it in 13 quarters. The position peaked at $6.43M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Commonwealth Retirement Investments reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Commonwealth Retirement Investments sold 7,579 Pfizer shares in Q1 2026, an estimated $189K.
  • Commonwealth Retirement Investments first reported a position in Pfizer in Q4 2022 and held it in 13 quarters.
  • Commonwealth Retirement Investments's Pfizer position peaked at $6.43M in Q4 2022.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.